| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 10/28/2004 | US20040214188 Diagnosis and treatment of diabetic , muscle, metabolic and eating disorders |
| 10/28/2004 | US20040213860 compositions which are effective in preventing and/or treating peptic ulcer diseases, comprising an effective amount of American ginseng and/or its extract |
| 10/28/2004 | US20040213842 Particularly a tetrodotoxin-resistant voltage-gated Na+ current (TTX-R INa) and/or activity-dependent sodium channel modulators to treat inflammatory bowel disorders, irritable bowel syndrome, slow-transit constipation, non-ulcer dyspepsia, an evacuation an evacuation disorder and functional dysphasia |
| 10/28/2004 | US20040213797 Conjugates for the modulation of immune responses |
| 10/28/2004 | US20040213769 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 10/28/2004 | US20040213442 Novel fatty acids analogous |
| 10/28/2004 | CA2526899A1 Method for the treatment of diseases linked to an accumulation of triglycerides and cholesterol |
| 10/28/2004 | CA2522322A1 Agent for treating diabetes mellitus |
| 10/28/2004 | CA2522266A1 Phenylazole compound, production process therefor and antioxidant |
| 10/28/2004 | CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling |
| 10/28/2004 | CA2521420A1 Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist |
| 10/28/2004 | CA2521369A1 The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome |
| 10/27/2004 | EP1471060A1 5,11-Dihydrodibenzo[b,e][1,4]-oxazepine derivatives as calcium channel antagonists |
| 10/27/2004 | EP1471055A1 6-phenylpyridyl-2-amine derivatives |
| 10/27/2004 | EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 10/27/2004 | EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 10/27/2004 | EP1470819A1 High drug load mesalazine sachet |
| 10/27/2004 | EP1470257A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 10/27/2004 | EP1470256A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE /GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 10/27/2004 | EP1470218A2 Corona-virus-like particles comprising functionally deleted genomes |
| 10/27/2004 | EP1470150A2 Corticosteroids nitrate derivatives |
| 10/27/2004 | EP1470148A2 Double-stranded oligonucleotides |
| 10/27/2004 | EP1470144A2 Oligonucleotides comprising alternating segments and uses thereof |
| 10/27/2004 | EP1470138A1 Mmp inhibitors |
| 10/27/2004 | EP1470137A1 Edg receptor agonists |
| 10/27/2004 | EP1470126A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor |
| 10/27/2004 | EP1470112A1 Substituted pyridazinones as inhibitors of p38 |
| 10/27/2004 | EP1470109A1 Metabolites of (3- [(4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl -phenoxy)-acetic acid |
| 10/27/2004 | EP1469882A2 Treatment of ms with goat serum |
| 10/27/2004 | EP1469867A1 Method of treating halitosis |
| 10/27/2004 | EP1469857A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis |
| 10/27/2004 | EP1469856A2 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 10/27/2004 | EP1469854A1 Condensed heterocyclic compounds |
| 10/27/2004 | EP1469846A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 10/27/2004 | EP1469842A2 Bicyclic cb2 cannabinoid receptor ligands |
| 10/27/2004 | EP1469839A2 Transmucosal delivery of proton pump inhibitors |
| 10/27/2004 | EP1469835A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 10/27/2004 | EP1469743A1 Stable hygroscopic compositions and methods for stabilizing hygroscopic ingredients |
| 10/27/2004 | EP1373263B1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 10/27/2004 | EP1246791B1 Aminomethyl-phenyl-cyclohexanone derivatives |
| 10/27/2004 | EP1137424B9 Preparation which contains oligosaccharides and probiotics |
| 10/27/2004 | EP1105391B1 Imidazo[1,2-a]pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for thier preparation |
| 10/27/2004 | EP0831791B1 Delivery of drugs to the lower gi tract |
| 10/27/2004 | CN1541277A Method of determing chemotherapeutic regimen based on glutachione-S-transferase pi expression |
| 10/27/2004 | CN1541224A Antagonistic anti-hTNFSF13b Human antibodies |
| 10/27/2004 | CN1541222A Antibodies to non-functional P 2 Chi 7 receptor diagnosis and treatment of cancers and other conditions |
| 10/27/2004 | CN1541219A Tricyclic imidazopyridines |
| 10/27/2004 | CN1541217A Chemical compounds |
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1541210A Arylsulfonyl derivatives with 5-HT6 receptor affinity |
| 10/27/2004 | CN1541203A 4-(phenyl-(piperidin-4-YL)-amino)-benzamide derivatives and their use for treatment of pain, anxiety or gastrointestinal disorders |
| 10/27/2004 | CN1541108A Vaccine compsn. comprising at least two valences, one enhanced with adjuvant and not other |
| 10/27/2004 | CN1541107A Growth factor complex |
| 10/27/2004 | CN1541106A Combination therapies using vitamin B12 and interferon for treatment of viral, proliferative and inflammatory diseases |
| 10/27/2004 | CN1541105A Combination therapies using vitamin B12 and interferon for treatment of viral, provliferative and inflammatory diseases |
| 10/27/2004 | CN1541102A Somatostain agonists |
| 10/27/2004 | CN1541093A Novel use of combined 5-HI1A agonists and selective serotonin reuptake inhibitors |
| 10/27/2004 | CN1539824A Compounds with analygesic effect |
| 10/27/2004 | CN1539504A Bacterin of tabling gene of E type hepatitis virus |
| 10/27/2004 | CN1539501A Tablet for keeping in mouth prepared from recombined human interferon alpha 2b and producing method |
| 10/27/2004 | CN1539500A Nose drops of recombined human interferon alpha 2b and preparing method |
| 10/27/2004 | CN1539498A Ganoderma lucidum tea for healthy vital spark and preparation method |
| 10/27/2004 | CN1539492A Medication for treating astriv disease, gastric ulcer and preparation technique |
| 10/27/2004 | CN1539490A Chinese traditional medicine for curing cholestatic hepatitis and preparing method |
| 10/27/2004 | CN1539489A Drug for treating chronic gastritis |
| 10/27/2004 | CN1539485A Oral liquid for preserving one's longevity |
| 10/27/2004 | CN1539483A Chinese traditional medicine for treating chronic liver disease and anti hepatic fibrosis |
| 10/27/2004 | CN1539460A Chinese materia medica preparation of prolonging life for invigorating the kidney yang and producing method |
| 10/27/2004 | CN1539436A Medicine for treating gastric disease and gallbladder disease |
| 10/27/2004 | CN1539434A Dryed emulsion of seabuckthorn fruit of Chinese traditional medicine and preparation method |
| 10/27/2004 | CN1539431A Powder of Chinese forest frog oil preparation method |
| 10/27/2004 | CN1539429A Deoxyadenosine in aplication of preparing bypolipidemic |
| 10/27/2004 | CN1539418A Preparation containing alkaloid of kuhseng and ramification for curing stomatocace in recurrence |
| 10/27/2004 | CN1539416A Medication for treating acute hepatitis and chronic hepatitis and preparation technique |
| 10/27/2004 | CN1539414A New medicinal preparation of sodium houttuynine sodium bisulfite and producing method |
| 10/27/2004 | CN1539402A Aqueous solution extracted from nucleus of hawkthom as fluid for proteting teeth |
| 10/27/2004 | CN1172929C Substituted indoles for modulating NFKB activity |
| 10/27/2004 | CN1172710C Pill capable of treating hepatogastric disease |
| 10/27/2004 | CN1172707C Chinese traditional medical preparation for activatnig spleen-energy, stimulating appetite, nourising and restoring qi |
| 10/27/2004 | CN1172691C Cholelithiasis treating medicine |
| 10/27/2004 | CN1172682C Application of sodium bicarbonate in preparing medicine for hepatitis |
| 10/27/2004 | CN1172676C Diamonium glycyrrhizanate transfusion preparation |
| 10/26/2004 | US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 10/26/2004 | US6809175 Cadherin derived growth factor and its use |
| 10/26/2004 | US6809113 For therapy of arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis transplant rejection |
| 10/26/2004 | US6809108 Selective muscarinic m3 receptor antagonts; reduced side effects |
| 10/26/2004 | US6809101 Compounds having anti-hepatitis C virus effect |
| 10/26/2004 | US6809100 Hydroxamic acid derivatives |
| 10/26/2004 | US6809098 Compounds |
| 10/26/2004 | US6809094 N-fused hetercyclo-1,4- or -1,5- diazabicyclo derivatives; nicotinic receptor agonists; central nervous system (cns) |
| 10/26/2004 | US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors |
| 10/26/2004 | US6809090 Nitrogen monoxide synthase and/or lipidic peroxidation inhibitors |
| 10/26/2004 | US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 10/26/2004 | US6809087 Sodium salt of 2-hydroxy-5-((4-(3-(4-((2-methyl-1h-imidazo-(4,5-c)pyridin-1-yl)methyl)-1 -piperidinyl)-3-oxo-1-phenyl-1-propenyl)phenyl)azo)benzoic acid; inflammatory bowel disease |
| 10/26/2004 | US6809083 Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections |
| 10/26/2004 | US6809077 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration |
| 10/26/2004 | US6808739 Drying method for selectively removing volatile components from wet coatings |
| 10/26/2004 | US6808723 Gastric acid secretion |
| 10/26/2004 | US6808710 Contacting cell expressing pd-1 with binding agent; genetic transduction of negative signal |
| 10/26/2004 | US6808702 Repopulation of cellular components (neurons, muscles, tissues); for treatment of degenerative, immunologic/ inflammatory, neoplastic, and idiopathic conditions of the gastrointestinal tract |